Exagen (XGN) Current Assets (2018 - 2026)

Exagen (XGN) has 9 years of Current Assets data on file, last reported at $43.6 million in Q1 2026.

• Quarterly Current Assets rose 34.08% year-over-year to $43.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $43.6 million (up 34.08% YoY) and the FY2025 annual result came in at $48.9 million, up 34.12% from the prior year.
• Current Assets declined to $43.6 million in Q1 2026, from $48.9 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $103.6 million in Q1 2022 to a low of $32.5 million in Q1 2025.
• A 5-year average of $55.5 million and a median of $48.9 million in 2023 frame the typical range for Current Assets.
• Annual changes were most pronounced in 2023 — Current Assets slumped 41.85% — and 2025, when it jumped 47.9%.
• Tracing XGN's Current Assets over 5 years: stood at $72.6 million in 2022, then slumped by 34.11% to $47.8 million in 2023, then slipped by 23.8% to $36.5 million in 2024, then jumped by 34.12% to $48.9 million in 2025, then declined by 10.86% to $43.6 million in 2026.
• The last three Current Assets figures came in at $43.6 million (Q1 2026), $48.9 million (Q4 2025), and $52.6 million (Q3 2025), per Business Quant data.